Table 1.
Baseline Characteristics
| CMC-TI N (%) | Usual care N (%) | |
|---|---|---|
| N | 236 | 239 |
| Age in years (mean ± SD) | 61.94 ± 11.44 | 60.52 ± 10.45 |
| Male | 121 (51.3) | 127 (53.1) |
| Type 2 diabetes | 229 (97.0) | 236 (98.7) |
| BMI (kg/m2) (mean ± SD) | 32.63 ± 6.83 | 33.03 ± 6.85 |
| Clinical outcomesa (mean ± SD) | ||
| HbA1c (%) | 7.3 ± 1.6 | 7.2 ± 1.6 |
| LDL-C (mg/dL) | 91.67 ± 32.41 | 97.67 ± 35.61 |
| SBP (mmHg) | 126.22 ± 16.87 | 131.39 ± 17.65 |
| Clinical risk levelb | ||
| High | 44 (18.6) | 40 (16.7) |
| Moderate | 112 (47.5) | 116 (48.5) |
| Low | 80 (33.9) | 83 (34.7) |
| Positive PHQ-9 | 60 (10.6) | —c |
All values reported are N(%) unless otherwise noted. All between-group P values >.05.
Experimental Conditions: In the CMC-TI group, an RN/CDE care manager, medical assistant health coach, and RN depression care manager utilized electronic medical record-based risk stratification reports, standardized decision-support tools, live and remote tailored treatments, and coaching to manage care. Usual care is usual diabetes care in the clinic.
Primary outcome analyses controlled for differences in baseline clinical values.
High risk: HbA1c ≥9%, OR HbA1c ≥8% and LDL ≥100 mg/dl and BP ≥140/90 mmHg. Moderate risk: HbA1c ≥8% and/or LDL ≥100 mg/dl and/or BP ≥140/90 mmHg. Low risk: HbA1c <8% and LDL <100 mg/dl and BP <140/90 mmHg.
Measure was collected as part of CMC-TI, and therefore data were not available for usual care participants.
BMI, body mass index; CDE, certified diabetes educator; CMC-TI, cardiometabolic care team intervention; HbA1c, glycosylated hemoglobin; LDL-C, low-density lipoprotein cholesterol; PHQ-9, Patient Health Questionnaire-9; RN, registered nurse; SBP, systolic blood pressure; SD, standard deviation.